{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T10:31:52Z","timestamp":1782642712601,"version":"3.54.5"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0082647","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T21:52:00Z","timestamp":1386021120000},"page":"e82647","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Rates of Fetal Polydrug Exposures in Methadone-Maintained Pregnancies from a High-Risk Population"],"prefix":"10.1371","volume":"8","author":[{"given":"Kaitlyn","family":"Delano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Gareri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/GCO.0b013e3282f1bf17","article-title":"The effects of drug abuse on pregnancy","volume":"19","author":"KM Kuczkowski","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10550881003684723","article-title":"Addiction in pregnancy","volume":"29","author":"J Keegan","year":"2010","journal-title":"J Addict Dis"},{"key":"ref3","first-page":"e441","article-title":"Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications","volume":"57","author":"L Kelly","year":"2011","journal-title":"Can Fam Physician"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0378-3782(77)90017-2","article-title":"The narcotic-dependent mother: fetal and neonatal consequences","volume":"1","author":"SR Kandall","year":"1977","journal-title":"Early Hum Dev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addbeh.2009.10.007","article-title":"Underreporting of use of cocaine and marijuana during the third trimester of gestation among pregnant adolescents","volume":"35","author":"MA Bessa","year":"2010","journal-title":"Addict Behav"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ntr\/ntq068","article-title":"Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits","volume":"12","author":"TR Gray","year":"2010","journal-title":"Nicotine Tob Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"F98","DOI":"10.1136\/fn.88.2.F98","article-title":"Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse","volume":"88","author":"B Bar-Oz","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinchem\/43.1.235","article-title":"Detection of intrauterine illicit drug exposure by newborn drug testing. National Academy of Clinical","volume":"43","author":"TC Kwong","year":"1997","journal-title":"Biochemistry - Clin Chem"},{"key":"ref9","first-page":"281","article-title":"Growth and development of endodermal structures. Scientific foundations in paediatrics","author":"V Miller","year":"1974"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.2008.156","article-title":"Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes","volume":"84","author":"SL Kacinko","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref11","first-page":"e177","article-title":"A review of substance abuse monitoring in a social services context: a primer for child protection workers","volume":"17","author":"M Moller","year":"2010","journal-title":"Can J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.clpt.6100506","article-title":"Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health","volume":"83","author":"G Koren","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2011.10.002","article-title":"Simultaneous detection of seventeen drugs of abuse and metabolites in hair using solid phase micro extraction (SPME) with GC\/MS","volume":"218","author":"K Aleksa","year":"2012","journal-title":"Forensic Sci Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.alcohol.2010.07.005","article-title":"An improved method for rapidly quantifying fatty acid ethyl esters in meconium suitable for prenatal alcohol screening","volume":"45","author":"JR Hutson","year":"2011","journal-title":"Alcohol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5055\/jom.2013.0153","article-title":"The use of urine drug monitoring in chronic opioid therapy: an analysis of current clinician behavior","volume":"9","author":"Z Clancy","year":"2013","journal-title":"J Opioid Manag"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jsat.2006.11.008","article-title":"Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing","volume":"33","author":"WB Jaffee","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00228-005-0035-5","article-title":"Changes to methadone clearance during pregnancy","volume":"61","author":"K Wolff","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/dmd.112.047118","article-title":"Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy","volume":"41","author":"LJ Dickmann","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v18n04_05","article-title":"Alterations in methadone metabolism during late pregnancy","volume":"18","author":"MA Jarvis","year":"1999","journal-title":"J Addict Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/14767058.2011.600371","article-title":"Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?","volume":"25","author":"JJ McCarthy","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref21","first-page":"795","article-title":"Comprehensive care of the pregnant addict and its effect on maternal and infant outcome","volume":"1","author":"LP Finnegan","year":"1971","journal-title":"ContemP. Drug Probs"},{"key":"ref22","article-title":"Breaking the cycle: The evaluation report (1995-2000). Toronto","author":"DJ Pepler","year":"2002","journal-title":"Health Canada"},{"key":"ref23","article-title":"Evaluation report of the Sheway Project for high-risk pregnant and parenting women","author":"N Poole","year":"2000"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ntt.2003.07.009","article-title":"A multifaceted intervention strategy for reducing substance use in high-risk women","volume":"25","author":"R Loudenburg","year":"2003","journal-title":"Neurotoxicol Teratol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009","volume":"127","author":"GK Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0082647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T06:09:12Z","timestamp":1597126152000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0082647"}},"subtitle":[],"editor":[{"given":"Markus\u00a0M.","family":"Heimesaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0082647","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}